Bronte Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,905
Closed -$7.74K 69
2026
Q1
$7.74K Hold
16,905
﹤0.01% 54
2025
Q4
$37.2K Buy
+16,905
New +$27.2K ﹤0.01% 35

Other funds holding GUTS

Bronte Capital Management's GUTS Position: Q2 2026 in Review

Bronte Capital Management sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 16,905 shares — an estimated $7.74K sold.

Bronte Capital Management first reported a position in GUTS in Q4 2025 and held it in 2 quarters. The position peaked at $37.2K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Bronte Capital Management reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
  • Bronte Capital Management sold 16,905 Fractyl Health shares in Q2 2026, an estimated $7.74K.
  • Bronte Capital Management first reported a position in Fractyl Health in Q4 2025 and held it in 2 quarters.
  • Bronte Capital Management's Fractyl Health position peaked at $37.2K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Bronte Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.